Everstone Capital is an Everstone Group, based in Mumbai, private equity arm. It is considering the sell of its healthcare platform in Asia, Everlife, which can be valued from $500 million to $1 billion. The preliminary interest from several private equity firms, as well as companies in the industry, has been shown.
Everlife, Singapore, was founded in 2014. Everlife is an Asian access and distribution partner for life science, analytical laboratory solutions, and diagnostics. The company offers its clients support within the whole product lifecycle – starting from regulatory and market building to applications and service support. Everlife aims to become the choice for clinical, industrial, and research laboratories in Asia. The company operates in India, Indonesia, the Philippines, Thailand, Singapore, and Malaysia.
Everstone Capital, Singapore, was founded by Atul Kapur and Sameer Sain in 2006. It is a focused investor in South East Asia and India with real estate and private equity funds. Besides investment in healthcare and pharmaceutical assets, Everstone Capital also invests in industrials, consumers, tech, and financial services.